BSO LLC recalls TESTOSTERONE PELLET 100 mg (with Cholesterol </=4%)…
BSO LLC recalls TESTOSTERONE PELLET 100 mg (with Cholesterol </=4%) and 4 more
- Published
- 14 May 2025
- Units affected
- 5 products
- Agency
- FDA
- Country
- United States
The hazard
Presence of Particulate Matter: Glass particles were found in pellet vials.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
TESTOSTERONE PELLET 100 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0101-01
TESTOSTERONE PELLET 200 mg BLUNT, 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0121-01
TESTOSTERONE PELLET 200 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0122-01
TESTOSTERONE PELLET 200 mg BLUNT (with Cholesterol </=2%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0124-01
TESTOSTERONE PELLET 200 mg (with Cholesterol </=2%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0125-01
- Brand / company
- BSO LLC
- Codes / lots
- Lot 20250102@6, exp 12/11/2025; Lot 20250130@4, exp 1/22/2026 | Lot 20250129@1, exp 1/17/2026; Lot 20250218@4, exp 1/25/2026 | Lot 20250205@6, exp 1/30/2026 | Lot 20250217@7, exp 1/31/2026 | Lot 20250207@1, exp 1/31/2026; Lot 20250228@1, exp 1/31/2026
- Distribution
- Nationwide in the USA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 14 May 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.